Results 241 to 250 of about 21,604,258 (289)
Refining the treatment of immune checkpoint inhibitor–associated myocarditis: Challenges, innovations and rechallenge considerations
British Journal of Pharmacology, EarlyView.Immune checkpoint inhibitor (ICI)‐associated myocarditis has emerged as a severe and clinically complex immune‐related toxicity that poses significant challenges for therapeutic decision‐making in routine cardio‐oncological care. High‐dose corticosteroids remain the first‐line therapy, yet their timing, dosage and tapering require careful clinical ...Raluca I. Mincu, Lisa Zimmer, Dimitra Vlachopoulou, Elias Haj‐Yehia, Julia Hoffmann, Lars Michel, Elisabeth Livingstone, Dirk Schadendorf, Alpaslan Tasdogan, Matthias Totzeck, Tienush Rassaf +10 morewiley +1 more sourceFATP2-mediated lipid metabolism enhances chimeric antigen receptor T-cell therapy resistance in B-cell acute lymphoblastic leukemia. [PDF]
LeukemiaGarcia C, Lyons KU, Contreras JG, Liu T, Donnelly AJ, Novak AJ, Argabright A, Anderson C, Grier A, Smith S, Michlin J, Olusoji J, Mikeska RG, Zhou X, Geng H, Rahkola JT, Patel HN, Jacot JG, Müschen M, D'Alessandro A, Dick JE, Iacobucci I, Mullighan CG, Reisz JA, Phang T, Eric Kohler M, Witkowski MT. +26 moreeuropepmc +1 more sourceChimeric Antigen Receptor T-Cell Therapy and Autoimmune Diseases in the Nervous System. [PDF]
Immun Inflamm DisYao SY, Du MQ, Yang H, Zeng QM, Zhou H, Zhang X, Kazuo S, Liu J, Lin LX, Kang XH, Jiang DY, Peng Y. +11 moreeuropepmc +1 more sourceReduced‐dose pegylated asparaginase reliably achieves therapeutic levels in adult patients with acute lymphoblastic leukaemia and lymphoblastic lymphoma
British Journal of Haematology, EarlyView.Leah A. Goldberg, Anjani D. Kapadia, Andrew S. Palmer, Lydia Benitez Colon, Bernard L. Marini, Anthony J. Perissinotti, Dale L. Bixby, Patrick W. Burke, Syed Abdul Mannan Shah, Hamed Rahmani Youshanlouei, Adam S. DuVall, John F. Cursio, Wendy Stock, Emily Dworkin, Anand A. Patel +14 morewiley +1 more sourceA Prospective Population-Based Study of Chimeric Antigen Receptor T-Cell Therapy for Patients with Diffuse Large B-Cell Lymphoma. [PDF]
Curr OncolMozessohn L, Villeneuve PJA, Somé NH, Mercer RE, Masucci L, Kouroukis T, Bredeson C, Aktar S, Guan Q, Prica A, Chen CI, Rodin D, Cheung MC, Chaudhry M, Gavura S, McKay C, Wong WWL, Chan KKW. +17 moreeuropepmc +1 more sourceInfections in Patients With Cytokine Release Syndrome/Immune Effector Cell-Associated Neurotoxicity Syndrome Following Chimeric Antigen Receptor T-Cell Therapy. [PDF]
Open Forum Infect DisGallardo-Pizarro A, Ariño M, Lopera C, Martinez-Urrea A, Terrones-Campos C, Castiella-Aranzasti A, González-Navarro EA, Albiol N, Teijon-Lumbreras C, Pitart C, Marcos MÁ, Ortíz-Maldonado V, Mensa J, Delgado J, Urbano-Ispizua Á, Fernández de Larrea C, Soriano A, Martinez-Cibrian N, Castro P, Garcia-Vidal C. +19 moreeuropepmc +1 more sourceTranscriptome Analysis Identifies a Myeloid-Like Signature in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy. [PDF]
Cancer MedWang S, Liu W, Wang Y, Xu Y, Xing H, Tang K, Tian Z, Rao Q, Qiu S, Wei H, Gu R, Wang M, Wang J. +12 moreeuropepmc +1 more sourceHaematological malignancies in paediatric and adolescents or young adults patients with Li‐Fraumeni syndrome: Retrospective multi‐institutional case series
British Journal of Haematology, EarlyView.Yoshiko Nakano, Keisuke Kato, Yuichi Mitani, Yuki Arakawa, Hidetaka Niizuma, Yoji Sasahara, Shinya Osone, Toshihiko Imamura, Misato Suzuki, Daisuke Hasegawa, Dai Keino, Eiji Nakata, Ryoji Kobayashi, Ryo Maemura, Nao Yoshida, Michio Ozeki, Moe Hidaka, Hiroyoshi Hattori, David Malkin, Motohiro Kato +19 morewiley +1 more source